PlainRecalls
FDA Drug Moderate Class II Terminated

Buprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial, (supplied in packages of 5 vials) Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-179-05

Reported: November 15, 2023 Initiated: November 9, 2021 #D-0087-2024

Product Description

Buprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial, (supplied in packages of 5 vials) Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-179-05

Reason for Recall

Crystallization: presence of white, crystalline product agglomeration observed in 2 vials during annual inspection of retain samples.

Details

Recalling Firm
PAR Sterile Products LLC
Distribution
Nationwide USA
Location
Rochester, MI

Frequently Asked Questions

What product was recalled?
Buprenorphine HCl, Injection, 0.3mg/mL, For Intramuscular or Intravenous Use, Rx Only, 1mL Single Dose Vial, (supplied in packages of 5 vials) Distributed by Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC: 42023-179-05. Recalled by PAR Sterile Products LLC.
Why was this product recalled?
Crystallization: presence of white, crystalline product agglomeration observed in 2 vials during annual inspection of retain samples.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 15, 2023. Severity: Moderate. Recall number: D-0087-2024.